Digital Cultivating data-driven decisions: How to use content experi... Data-driven decisions matter, and it is hardly surprising when looking at statistics.
Digital Create, approve, deploy: supercharge comms with modular cont... Each year, pharma and life sciences invest large amounts of time and money in creating content designed to attract HCPs and call them to action.
News MSD stops trials of BTK inhibitor for blood cancers MSD has stopped development of BTK inhibitor nemtabrutinib, acquired via its $2.7bn takeover of ArQule, after trial results pointed to a safety issue.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.